Biortus

Congratulations on Rivastigmine Tartrate Project Passed the On-site Verification by a Listed Pharmaceutical Company

Biortus has passed the on-site verification of active pharmaceutical ingredient (API) Rivastigmine tartrate process development by a listed pharmaceutical company.

2018

/

07

< 1234 >

Copyright © 2020 Biortus Biosciences Co.,Ltd.  Power by www.300.cn

MESSAGE

Submit
%{tishi_zhanwei}%